Technology of surgical endoscopy for gallbladder pathology
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S334
DOI: 10.1055/s-0044-1783511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von O. Babii und 2 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Aims
To study the effectiveness of the combined technology of organ-preserving surgical endoscopy for gallbladder (GB) pathology.
Methods
We analysed the results of endosurgical treatment of 134 patients with pathology of the GB (January 2014 to November 2023): cholelithiasis in 112 cases, combination of cholelithiasis with cholesterol polyps of the GB in 16 cases, single polyps of the GB in 6 cases. The main selection criterion was ultrasonography with determination of the structure, signs of active inflammation and motor function of the GB, mobility of gallstones, polyps without invasion into the GB wall. The technology of the operation included laparoscopic access to the GB using three trocars. Cholecystotomy with electrocoagulation in the area of the GB bottom was performed. Bile aspiration with subsequent sanation of the GB cavity was performed. For revision and manipulation in the GB cavity a flexible endoscope of 5 mm diameter with a working channel of 2 mm was used, which was carried out through a trocar. Lithoextraction was performed using a Dormia basket with the size of 10 mm and 30 mm. Polypectomy loops of 10 mm size, hot biopsy forceps, coagulation electrode were used during polyp removal. The integrity of the GB wall was restored intracorporeally with continuous precision sutures using monofilament absorbable suture. In the postoperative period, a rehabilitation programme was prescribed to prevent recurrence of gallstones.
Results
All patients underwent organ-preserving operations on the GB – endoscopic cholecystolithoextraction (n=112), cholecystolithoextraction with cholecystopolypectomy (n=16), cholecystopolypectomy (n=6) under laparoscopic control. The number of removed gallstones ranged from 1 to 80 with sizes ranging from 2 to 30 (17.6±3.2) mm in diameter. In 22 cases after lithoextraction at endoscopic revision of the GB cavity small gallstones 0.5-1 mm in diameter were diagnosed in the mucous membrane folds, which were removed during sanation through the endoscope channel. In 16 cases, besides lithoextraction, cholesterol polyps 3-6 mm in size were removed. In 4 cases single inflammatory polyps of 10-14 mm in size were removed. In 2 cases single adenomatous polyps of 12 and 16 mm were removed. The polyps were histologically verified. Duration of operative intervention was 80-145 (90.26±18.10) min. True recurrence of gallstones within the period from 6 months to 10 years was diagnosed in 8 (7.8%) out of 106 (82.8%) examined patients. The causes of recurrence were the development of cholestasis due to acquired metabolic syndrome, hormonal dysfunction, viral hepatitis, covid-19. No recurrence of polyps was noted.
Conclusions
1. The technology of organ-preserving surgical endoscopy is the optimal way to treat gallstones and polyps of the GB. 2. Endoscopic revision of the GB cavity allows to detect and remove gallstones from the mucosal folds not diagnosed by ultrasonography. [ 1 ] [ 2 ] Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Babii, O., Shevchenko, B., & Tarabarov, S. (2024). Technology of surgical endoscopy for gallbladder pathology. Endoscopy, 56(S 02 S 02), S334. https://doi.org/10.1055/s-0044-1783511
Vancouver
Babii O, Shevchenko B, Tarabarov S. Technology of surgical endoscopy for gallbladder pathology. Endoscopy. 2024;56(S 02 S 02):S334. doi:10.1055/s-0044-1783511
BibTeX
@article{Babii2024,
author = {Babii, O. and Shevchenko, B. and Tarabarov, S.},
title = {Technology of surgical endoscopy for gallbladder pathology},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S334},
doi = {10.1055/s-0044-1783511}
}
EUVIMED